The Effect of Hormone Therapy on Mean Blood Pressure and Visit-to-visit Blood Pressure Variability in Postmenopausal Women: Results from the Women's Health Initiative Randomized Controlled Trials

Overview

Journal J Hypertens

Specialty Cardiology & Vascular Diseases

Date 2014 Jul 4

PMID 24991872

Citations 14

Authors

Daichi Shimbo

Lu Wang

Michael J LaMonte

Matthew Allison

Gregory A Wellenius

Anthony A Bavry

Lisa W Martin

Aaron Aragaki

Jonathan D Newman

Yael Swica

Jacques E Rossouw

JoAnn E Manson

Sylvia Wassertheil-Smoller

Affiliations

Soon will be listed here.

Abstract

Objectives: Mean and visit-to-visit variability (VVV) of blood pressure (BP) are associated with an increased cardiovascular disease risk. We examined the effect of hormone therapy on mean and VVV of BP in postmenopausal women from the Women's Health Initiative (WHI) randomized controlled trials.

Methods: BP was measured at baseline and annually in the two WHI hormone therapy trials, in which 10 739 and 16 608 postmenopausal women were randomized to conjugated equine estrogens (CEEs, 0.625 mg/day) or placebo, and CEEs and medroxyprogesterone acetate (MPA, 2.5 mg/day) or placebo, respectively.

Results: At the first annual visit (year 1), mean SBP was 1.04 mmHg [95% confidence interval (CI) 0.58, 1.50] and 1.35 mmHg (95% CI 0.99, 1.72) higher in the CEEs and CEEs and MPA arms, respectively, compared with the corresponding placebos. These effects remained stable after year 1. CEEs also increased the VVV of SBP (ratio of VVV in CEEs vs. placebo, 1.03; P < 0.001), whereas CEEs and MPA did not (ratio of VVV in CEEs and MPA vs. placebo, 1.01; P = 0.20). After accounting for study drug adherence, the effects of CEEs and CEEs and MPA on mean SBP increased at year 1, and the differences in the CEEs and CEEs and MPA arms vs. placebos also continued to increase after year 1. Further, both CEEs and CEEs and MPA significantly increased the VVV of SBP (ratio of VVV in CEEs vs. placebo, 1.04; P < 0.001; ratio of VVV in CEEs and MPA vs. placebo, 1.05; P < 0.001).

Conclusion: Among postmenopausal women, CEEs and CEEs and MPA at conventional doses increased mean and VVV of SBP.

Citing Articles

Accuracy of self-reported treated hypertension in the women's health initiative: Comparisons with medication inventories.

LaMonte M, Milton G, Miller C, Hovey K, Soliman A, Millen A J Clin Hypertens (Greenwich). 2024; 26(10):1171-1180.

PMID: 39161156 PMC: 11476737. DOI: 10.1111/jch.14889.

Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study.

Go G, Oh H, Han K, Kim Y, Lee H, Lee J J Korean Med Sci. 2023; 38(49):e377.

PMID: 38111280 PMC: 10727922. DOI: 10.3346/jkms.2023.38.e377.

Association of blood pressure variability with Endothelin-1 by menopause status among Black women: findings from the Jackson Heart Study.

Rethy L, Polsinelli V, Muntner P, Bello N, Cohen J J Hum Hypertens. 2023; 37(8):742-745.

PMID: 36966225 PMC: 11097102. DOI: 10.1038/s41371-023-00824-y.

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?.

Cho L, Kaunitz A, Faubion S, Hayes S, Lau E, Pristera N Circulation. 2023; 147(7):597-610.

PMID: 36780393 PMC: 10708894. DOI: 10.1161/CIRCULATIONAHA.122.061559.

The Association Between Route of Post-menopausal Estrogen Administration and Blood Pressure and Arterial Stiffness in Community-Dwelling Women.

Kalenga C, Hay J, Boreskie K, Duhamel T, MacRae J, Metcalfe A Front Cardiovasc Med. 2022; 9:913609.

PMID: 35757351 PMC: 9226418. DOI: 10.3389/fcvm.2022.913609.

References

Rossouw J, Manson J, Kaunitz A, Anderson G . Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol. 2012; 121(1):172-6. PMC: 3547645. DOI: 10.1097/aog.0b013e31827a08c8. View

Staessen J, Fagard R, Thijs L, Celis H, Arabidze G, Birkenhager W . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350(9080):757-64. DOI: 10.1016/s0140-6736(97)05381-6. View

Scuteri A, Bos A, Brant L, Talbot L, Lakatta E, Fleg J . Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med. 2001; 135(4):229-38. DOI: 10.7326/0003-4819-135-4-200108210-00007. View

. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998; 19(1):61-109. DOI: 10.1016/s0197-2456(97)00078-0. View

Kotchen J, Kotchen T . Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies. Curr Hypertens Rep. 2003; 5(6):505-12. DOI: 10.1007/s11906-003-0059-0. View

Ichikawa J, Sumino H, Ichikawa S, Ozaki M . Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens. 2006; 19(7):744-9. DOI: 10.1016/j.amjhyper.2005.10.006. View

Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P . The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens. 2002; 16(7):509-16. DOI: 10.1038/sj.jhh.1001431. View

Tatchum-Talom R, Martel C, Marette A . Influence of estrogen on aortic stiffness and endothelial function in female rats. Am J Physiol Heart Circ Physiol. 2002; 282(2):H491-8. DOI: 10.1152/ajpheart.00589.2001. View

Howard V, Cushman M, Pulley L, Gomez C, Go R, Prineas R . The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005; 25(3):135-43. DOI: 10.1159/000086678. View

10.

Shimbo D, Shea S, McClelland R, Viera A, Mann D, Newman J . Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2013; 26(7):896-902. PMC: 3693480. DOI: 10.1093/ajh/hpt040. View

11.

Szekacs B, Vajo Z, Acs N, Hada P, Csuzi L, Bezeredi J . Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension. Menopause. 2000; 7(1):31-5. DOI: 10.1097/00042192-200007010-00006. View

12.

Rothwell P, Howard S, Dolan E, OBrien E, Dobson J, Dahlof B . Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375(9718):895-905. DOI: 10.1016/S0140-6736(10)60308-X. View

13.

Webb A, Fischer U, Mehta Z, Rothwell P . Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010; 375(9718):906-15. DOI: 10.1016/S0140-6736(10)60235-8. View

14.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

15.

Scott A, Dhindsa P, Forsyth J, Mansell P . Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes Obes Metab. 2003; 6(1):16-22. DOI: 10.1111/j.1463-1326.2004.00294.x. View

16.

Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K . Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens. 2011; 5(3):184-92. DOI: 10.1016/j.jash.2011.03.001. View

17.

Anderson G, Limacher M, Assaf A, Bassford T, Beresford S, Black H . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004; 291(14):1701-12. DOI: 10.1001/jama.291.14.1701. View

18.

Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett D, Oparil S . The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011; 57(2):160-6. DOI: 10.1161/HYPERTENSIONAHA.110.162255. View

19.

Pickering T, Hall J, Appel L, Falkner B, Graves J, Hill M . Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart.... Circulation. 2005; 111(5):697-716. DOI: 10.1161/01.CIR.0000154900.76284.F6. View

20.

Karalis I, Beevers G, Beevers M, Lip G . Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. Blood Press. 2005; 14(1):38-44. DOI: 10.1080/08037050510008788. View